跳至主要内容
临床试验/NCT03535519
NCT03535519Unknown不适用

Rheumatoid Arthritis Ultrasound Response to Methotrexate

Juan Carlos Nieto1 个研究点 分布在 1 个国家目标入组 50 人开始时间: 2018年8月7日最近更新:
适应症
相关药物

试验速览

阶段
不适用
发起方
入组人数
50
试验地点
1
主要终点
Ultrasound response

研究概览

简要总结

Observational and prospective study of the ultrasound response to methotrexate in rheumatoid arthritis patients who started methotrexate

详细描述

  • Rheumatoid arthritis patients with active disease who start subcutaneous methotrexate by their rheumatologist prescription methotrexate will be included.
  • Patients will participate in a prospective and observational study in which the response to methotrexate will be assessed by ultrasound (US) of joints and tendons.
  • The main objective of the study is the change in B mode and Doppler mode US after 24 weeks of methotrexate treatment.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Active rheumatoid arthritis fulfilling EULAR criteria.
  • Prescription of methotrexate by a rheumatologist.
  • Informed consent signed by the patient.

排除标准

  • 未提供

结局指标

主要结局

Ultrasound response

时间窗: Basal and at 6 months

Change in B mode and Doppler mode synovitis and tenosynovitis

次要结局

  • Clinical response(Basal and 6 months)
  • Functional response(Basal and 6 months)

研究者

发起方
Juan Carlos Nieto
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Juan Carlos Nieto

Principal investigator

Hospital General Universitario Gregorio Marañon

研究点 (1)

Loading locations...

相似试验